Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 1999;81:505-511; doi:10.1136/hrt.81.5.505
Copyright © 1999 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 1999;81:505-511 ( May )

Effects of L- and D-arginine on the basal tone of human diseased coronary arteries and their responses to substance P

D Tousoulis,a C Tentolouris,a T Crake,b G Katsimaglis,a C Stefanadis,a P Toutouzas,a G J Daviesb

a Cardiology Unit, Hippokration Hospital, Athens University Medical School, Athens, Greece, b Cardiology Unit, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK

Correspondence to: Dr Davies.

Accepted for publication 26 November 1998

OBJECTIVE---To assess the effects of substance P administration alone and in combination with L- and D-arginine in patients with normal angiograms and in patients with coronary artery disease.
DESIGN---Intracoronary infusions of (a) normal saline, (b) the receptor mediated nitric oxide stimulant substance P (5.6 and 27.8 pmol/min) before and after L- or D-arginine (50 and 150 µmol/min), and (c) glyceryl trinitrate (250 µg bolus) were given to 17 patients with coronary artery disease and stable angina, and to six patients with normal angiograms. The diameter of angiographically normal proximal and distal segments and coronary stenoses were measured by computerised quantitative angiography.
RESULTS---L-arginine administration was associated with significant dilatation of stenoses (p < 0.01) of proximal segments of both "normal" (p < 0.05) and diseased (p < 0.01) arteries, and of distal segments of diseased arteries (p < 0.01). No significant changes were associated with D-arginine administration. Dose dependent dilatation of all segments including stenoses, was observed with substance P both before and after L-arginine infusion (p < 0.01). The magnitude of dilatation of stenoses and all segments of both "normal" and diseased coronaries was greater after L-arginine (p < 0.05) but not D-arginine and substance P infusion, than it was after saline and substance P infusion. Administration of D- or L-arginine did not change the magnitude of substance P induced dilatation.
CONCLUSIONS---Diseased and "normal" coronary arteries dilated in response to substance P and L-arginine but were unaffected by D-arginine infusion. The magnitude of the response to substance P was not increased by L-arginine administration, indicating that it is not critically dependent on the availability of substrate for nitric oxide synthase.


Keywords: endothelium; nitric oxide; coronary artery disease; L-arginine; vasomotor tone

© 1999 by Heart
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Tousoulis, D, Xenakis, C, Tentolouris, C, Davies, G, Antoniades, C, Crake, T, Stefanadis, C (2005). Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina. Heart 91: 1319-1323 [Abstract] [Full Text]  
  • Tentolouris, C., Tousoulis, D., Stefanadis, C. (2004). L-Arginine "Paradox" in Coronary Atherosclerosis. Circulation 110: e71-e71 [Full Text]  
  • Tousoulis, D, Davies, G J, Tentolouris, C, Crake, T, Goumas, G, Stefanadis, C, Toutouzas, P (2003). Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries. Heart 89: 531-534 [Abstract] [Full Text]  
  • Tousoulis, D., Antoniades, C., Tentolouris, C., Goumas, G., Stefanadis, C., Toutouzas, P. (2002). L-Arginine in cardiovascular disease: dream or reality?. Vasc Med 7: 203-211 [Abstract]  
  • Tousoulis, D, Davies, G J, Crake, T, Toutouzas, P C (2002). Vasomotion and nitric oxide bioactivity in diseased coronary arteries. Heart 87: 320-321 [Abstract] [Full Text]  
  • Chowdhary, S., Nuttall, S. L., Coote, J. H., Townend, J. N. (2002). L-Arginine Augments Cardiac Vagal Control in Healthy Human Subjects. Hypertension 39: 51-56 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Show me all >>